ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fever"

  • Abstract Number: 1211 • 2013 ACR/ARHP Annual Meeting

    Adult Autoinflammatory Phenotypes Associated With Heterozygous MEFV Mutations: A Continuum of Familial Mediterranean Fever?

    Qingping Yao, Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Familial Mediterranean fever (FMF) is traditionally regarded as an autosomal recessive disease characterized by periodic fever, serositis, erysipelas-like erythema and good response to colchicine. The…
  • Abstract Number: 894 • 2013 ACR/ARHP Annual Meeting

    Intermittent Fever, Immune Dysregulation, and Systemic Vasculopathy Due To Loss-Of-Function Mutations In Adenosine Deaminase2

    Qing Zhou1, Dan Yang2, Andrey Zavialov3, Amanda Ombrello4, Hyesun Kuehn5, Jae Jin Chae6, Anton Zavialov3, David Chin7, Deborah Stone8, Camilo Toro9, Joshua Milner10, Chyi-chia Lee11, Edward Cowen12, Fabio Candotti13, Elaine Remmers7, Susan Moir14, Raman Sood15, Shawn Burgess16, Massimo Gadina17, Sergio Rosenzweig18, Michael Hershfield19, Daniel L. Kastner20, Manfred Boehm2 and Ivona Aksentijevich7, 1Inflammatory Disease Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 2Laboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 3Turku Centre for Biotechnology, University of Turku, Turku, Finland, 4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 5Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, 6Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 7Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 8National Human Genome Research Institute, Bethesda, MD, 9NIH Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 10Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 11National Cancer Institute, National Institutes of Health, Bethesda, MD, 12Dermatology Consultation Servce, National Cancer Institute, National Institutes of Health, Bethesda, MD, 13Disorder of Immunity Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 14Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 15Zebrafish Core, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 16Developmental Genomics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 17Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 18National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 19Department of Medicine, Duke University Medical Center, Durham, NC, 20Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD

    Background/Purpose: We observed a syndrome characterized by intermittent fevers and livedoreticularis, systemic inflammation, hepatosplenomegaly, cytopenias, vasculopathy, and early-onset lacunar strokes in five unrelated patients.  We…
  • Abstract Number: 2024 • 2012 ACR/ARHP Annual Meeting

    Articular Symptoms in Cryopyrin-Associated Periodic Syndrome: Retrospective French Study

    Laetitia Houx1, Pierre Quartier2, Isabelle Kone-Paut3, Xavier Guennoc4, Pascal Pillet5, Thierry Lequerre6, Irene Lemelle7, Mohamed Hamidou8, Gilles Grateau9, Eric Hachulla10, Jean-Marie Berthelot11, Benedicte Neven12, Christophe Richez13, Anne Pagnier14, Veronique Hentgen15 and Valerie Devauchelle-Pensec16, 1Physical Medical Rehabilitation, Brest, France, 2Necker-Enfants Malades Hospital,, Paris, France, 3Pediatrics, Hospital Kremlin Bicêre, Kremlin-Bicêtre, France, 4Rheumatology, Hopital de Saint Brieuc, France, 5Paediatry, CHU, Bordeaux, France, 6Rheumatology, Rouen, France, 7Paediatry, CHU, Nancy, France, 8Internal Medicine Department, Nantes University Hospital, Nantes, France, 9Service De Médecine Interne, Hopital Tenon, Paris, France, 10Department of Internal Medicine, Claude Huriez University Hospital, Lille, France, 11Rheumatology Unit, Nantes University Hospital, Nantes, France, 12Inserm U768, Paris, France, 13Rheumatology, Hôpital Pellegrin and Université Victor Segalen Bordeaux, Bordeaux, France, 14Service de pediatrie, Grenoble, France, 15Versailles Hospital, Le Chesnay Cedex, France, 16Department of rheumatology and unit of immunology (EA2216), Brest Occidentale university, Brest, France

    Background/Purpose: The cryopyrin-associated periodic syndrome (CAPS) is a rare inherited inflammatory disease associated with a mutation in the NLRP3 gene. Articular symptoms are often described…
  • Abstract Number: 2025 • 2012 ACR/ARHP Annual Meeting

    Clinical Characteristics and Therapy Response in a Large Single-Centre Cohort of Patients with Periodic Fever with Aphtous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome

    Francesca Ricci1, Antonella Meini1, Lucio Verdoni2, Laura Dotta1, Marta Bolis2, Marco Berlucchi3, Gianfranco Savoldi4 and Marco Cattalini2, 1Pediatric Clinic, University of Brescia and Spedali Civili di Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 2Pediatric Clinic, Spedali Civili di Brescia and University of Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 3Spedali Civili di Brescia, Department of Pediatric Otorhinolaryngology, Brescia, Italy, 4Spedali Civili di Brescia, Angelo Nocivelli Institute of Molecular Medicine, Brescia, Italy

    Background/Purpose: PFAPA (Period Fever with Aphtous stomatitis, Pharyngitis and cervical Adenitis), is a periodic syndrome described for the first time in 1987 by Marshall et…
  • Abstract Number: 189 • 2012 ACR/ARHP Annual Meeting

    Pedal Swelling As a Characteristic Phenotype of the New Category of Autoinflammatory Disease Associated with NOD2 Gene Mutations

    Qingping Yao, Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Autoinflammatory diseases are characterized by seemingly unprovoked episodes of inflammation, without high titer autoantibodies or antigen specific T cells, and derive from genetic variants…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology